Trulieve Cannabis Corp. (OTCQX: TCNNFrevenue in 2022 was $1.2 billion, a 32% increase compared to $938 million in 2021. In the fourth quarter of 2022, the company had a revenue of $302 million, a 1% decrease compared to $305 million in the same period of 2021, and a net loss of $77 million, compared to a net loss of $72 million in the same quarter of 2021.

One of the largest multi-state cannabis operators achieved a positive adjusted EBITDA of $85 million in the quarter, representing a 16% decrease compared to $101 million in Q4 2021.

The Analyst

Cantor Fitzgerald’s analyst Pablo Zuanic, kept an ‘Overweight’ rating and lowered the price target on Trulieve …

Full story available on